We are live on ! Find out more
Vulcan Value Partners

Vulcan Value Partners Portfolio holdings

AUM $3.13B Turnover 15.79%
1-Year Est. Return 1.96%
 

Vulcan Value Partners is a value investing firm founded in 2007 by C.T. Fitzpatrick, a former principal and portfolio manager at Southeastern Asset Management. Fitzpatrick is its principal owner, chief investment officer and chief executive. Its analysts look for publicly traded companies that are competitively entrenched and can be bought at a margin of safety, keeping a shortlist of stable businesses they call the MVP list. Vulcan runs these strategies through individually managed portfolios, mutual funds and private funds for individuals and institutions, including charities and pension plans. Enduring Equity Holdings, formerly a Vulcan subsidiary, became an independent company at the end of 2025.

This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
-1.96%
3 Year Est. Return
+41.67%
5 Year Est. Return
+23.29%
10 Year Est. Return
+235.87%
AUM
$11.2B
AUM Growth
+$339M
Cap. Flow
-$217M
Cap. Flow %
-1.93%
Top 10 Hldgs %
44.36%
Holding
67
New
9
Increased
16
Reduced
29
Closed
13
Avg Time Held
1.8 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$432M
2
CAH icon
Cardinal Health
CAH
+$313M
3
COR icon
Cencora
COR
+$304M
4
MCK icon
McKesson
MCK
+$261M
5
CBRE icon
CBRE Group
CBRE
+$217M

Top Sells

Rank Stock Value
1
BEN icon
Franklin Templeton
BEN
+$329M
2
PH icon
Parker-Hannifin
PH
+$252M
3
TROW icon
T. Rowe Price
TROW
+$161M
4
BA icon
Boeing
BA
+$149M
5
RTX icon
RTX
RTX
+$147M

Sector Composition

Rank Sector Weight
1 Financials 27.88%
2 Healthcare 19.41%
3 Technology 18.48%
4 Consumer Discretionary 10.7%
5 Industrials 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ORCL icon
1
Oracle
ORCL
$359B
$870M 7.75%
22,633,884
+299,598
+1% +$11.7M
2013 Q2
14 quarters
NOV icon
2
NOV
NOV
$6.03B
$610M 5.43%
16,295,053
-2,053,756
-11% -$74.8M
2015 Q1
7 quarters
AXS icon
3
AXIS Capital
AXS
$7.75B
$518M 4.62%
7,943,351
-409,043
-5% -$24.6M
2014 Q3
9 quarters
MCK icon
4
McKesson
MCK
$128B
$486M 4.33%
3,461,194
+1,775,467
+105% +$261M
2016 Q3
1 quarter
ELV icon
5
Elevance Health
ELV
$93.8B
$439M 3.91%
3,050,319
-111,728
-4% -$15M
2014 Q1
11 quarters
EG icon
6
Everest Group
EG
$16B
$429M 3.82%
1,981,260
-88,158
-4% -$18.2M
2013 Q2
14 quarters
COR icon
7
Cencora
COR
$68.1B
$425M 3.79%
5,440,860
+3,892,674
+251% +$304M
2016 Q2
2 quarters
CVS icon
8
CVS Health
CVS
$110B
$421M 3.75%
+5,334,307
New +$432M
2016 Q4
0 quarters
MA icon
9
Mastercard
MA
$563B
$395M 3.52%
3,823,683
-94,704
-2% -$9.8M
2013 Q2
14 quarters
DISCK
10
DELISTED
Discovery Series C
DISCK
$386M 3.44%
14,410,942
-379,005
-3% -$10M
2013 Q2
14 quarters
STT icon
11
State Street
STT
$45.5B
$378M 3.37%
4,865,592
-339,767
-7% -$25.6M
2014 Q2
10 quarters
V icon
12
Visa
V
$778B
$378M 3.36%
4,839,570
+79,656
+2% +$6.4M
2013 Q2
14 quarters
HLT icon
13
Hilton
HLT
$83.2B
$363M 3.23%
4,450,234
-165,410
-4% -$12.2M
2016 Q1
3 quarters
CAH icon
14
Cardinal Health
CAH
$64.5B
$312M 2.78%
+4,332,718
New +$313M
2016 Q4
0 quarters
QRVO icon
15
DELISTED
Qorvo
QRVO
$306M 2.73%
5,803,082
+1,001,936
+21% +$54.5M
2016 Q3
1 quarter
SWKS icon
16
Skyworks Solutions
SWKS
$20.2B
$297M 2.64%
3,972,476
-1,051,612
-21% -$81M
2016 Q3
1 quarter
FOSL icon
17
Fossil Group
FOSL
$480M
$294M 2.62%
11,369,693
-114,629
-1% -$3.45M
2014 Q3
9 quarters
BA icon
18
Boeing
BA
$130B
$290M 2.58%
1,860,523
-1,022,346
-35% -$149M
2014 Q3
9 quarters
BNY icon
19
Bank of New York Mellon
BNY
$101B
$280M 2.5%
5,913,757
-3,077,218
-34% -$139M
2013 Q2
14 quarters
CBRE icon
20
CBRE Group
CBRE
$38.4B
$236M 2.11%
+7,509,946
New +$217M
2016 Q4
0 quarters
DIS icon
21
Walt Disney
DIS
$202B
$227M 2.02%
2,177,854
-33,049
-1% -$3.22M
2013 Q2
14 quarters
BEN icon
22
Franklin Templeton
BEN
$17.9B
$214M 1.9%
5,400,910
-8,789,020
-62% -$329M
2013 Q2
14 quarters
IHG icon
23
InterContinental Hotels
IHG
$26B
$199M 1.78%
+4,090,716
New +$185M
2016 Q4
0 quarters
CSCO icon
24
Cisco
CSCO
$374B
$177M 1.58%
5,871,339
-748,318
-11% -$22.8M
2013 Q2
14 quarters
AET
25
DELISTED
Aetna Inc
AET
$173M 1.54%
1,394,753
-77,493
-5% -$9.28M
2014 Q2
10 quarters

Similar funds

Vulcan Value Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Vulcan Value Partners held 67 positions worth $11.2B, up 3.1% from $10.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Vulcan Value Partners's Q4 2016 filing shows 9 new, 16 increased, 29 reduced and 13 closed positions. Its largest new stake was CVS Health: 5,334,307 shares worth $421M. The largest sale was Franklin Templeton, an estimated $329M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 33% a quarter earlier, followed by Healthcare and Technology.

  • Vulcan Value Partners's largest Q4 2016 buy was CVS Health: 5,334,307 shares worth $421M.
  • Vulcan Value Partners added most to Cencora in Q4 2016, an estimated $304M increase.
  • Vulcan Value Partners's biggest Q4 2016 reduction was Franklin Templeton, cutting an estimated $329M.
  • Vulcan Value Partners fully exited T. Rowe Price in Q4 2016, selling an estimated $161M.
  • Vulcan Value Partners's ten largest holdings make up 44% of its $11.2B portfolio in Q4 2016.
  • Vulcan Value Partners opened 9 new positions and closed 13 in Q4 2016.
  • Vulcan Value Partners's portfolio value rose 3.1% quarter-over-quarter to $11.2B.

Based on Vulcan Value Partners's 13F filing for Q4 2016, filed 14 Feb 2017.